AXSM250321P00097500 Option on Axsome Therapeutics

AXSM Stock  USD 127.54  1.13  0.89%   
AXSM250321P00097500 is a PUT option contract on Axsome Therapeutics' common stock with a strick price of 97.5 expiring on 2025-03-21. The contract was not traded in recent days and, as of today, has 20 days remaining before the expiration. The option is currently trading at an ask price of $2.2. The implied volatility as of the 1st of March is 20.0.
  
When exercised, put options on Axsome Therapeutics produce a short position in Axsome Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Axsome Therapeutics' downside price movement.

Rule 16 of 2025-03-21 Option Contract

The options market is anticipating that Axsome Therapeutics will have an average daily up or down price movement of about 0.0563% per day over the life of the option. With Axsome Therapeutics trading at USD 127.54, that is roughly USD 0.0718. If you think that the market is fully understating Axsome Therapeutics' daily price movement you should consider buying Axsome Therapeutics options at that current volatility level of 0.9%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Put Option on Axsome Therapeutics

An 'Out of The Money' option on Axsome has a strike price that Axsome Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Axsome Therapeutics' 'Out of The Money' options include buying the options if you expect a big move in Axsome Therapeutics' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Put Contract NameAXSM250321P00097500
Expires On2025-03-21
Days Before Expriration20
Vega0.045328
Gamma0.00565
Theoretical Value1.1
Open Interest28
Strike Price97.5
Last Traded At0.73
Current Price Spread0.0 | 2.2
Rule 16 Daily Up or DownUSD 0.0718

Axsome short PUT Option Greeks

Axsome Therapeutics' Option Greeks for the contract ending on 2025-03-21 at a strike price of 97.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Axsome Therapeutics' option greeks, its implied volatility helps estimate the risk of Axsome Therapeutics stock implied by the prices of the options on Axsome Therapeutics' stock.
Delta-0.082255
Gamma0.00565
Theta-0.100757
Vega0.045328
Rho-0.005871

Axsome long PUT Option Payoff at expiration

Put options written on Axsome Therapeutics grant holders of the option the right to sell a specified amount of Axsome Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Axsome Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Axsome Therapeutics is like buying insurance aginst Axsome Therapeutics' downside shift.
   Profit   
Break Even 96.4Strike Price 97.5Current Price 127.54100%
       Axsome Therapeutics Price At Expiration  

Axsome short PUT Option Payoff at expiration

By selling Axsome Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Axsome Therapeutics will generally make money when the underlying price is above the strike price. Therefore Axsome Therapeutics' put payoff at expiration depends on where the Axsome Stock price is relative to the put option strike price. The breakeven price of 96.4 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Axsome Therapeutics' price. Finally, at the strike price of 97.5, the payoff chart is constant and positive.
   Profit   
Break Even 96.4Strike Price 97.5Current Price 127.54100%
       Axsome Therapeutics Price At Expiration  
View All Axsome Therapeutics Options

Axsome Therapeutics Available Put Options

Axsome Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Axsome. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Axsome. It also shows strike prices and maturity days for a Axsome Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
 Put
AXSM250417P001100001110.00.3 - 2.752.6Out
 Put
AXSM250417P001150001115.01.6 - 4.03.37Out
 Put
AXSM250417P001200006120.03.0 - 6.74.7Out
 Put
AXSM250417P001250003125.05.0 - 8.67.2Out
 Put
AXSM250417P001300002130.08.1 - 11.29.7In
 Put
AXSM250417P0014000015140.014.2 - 18.013.8In
 Put
AXSM250417P001550001155.026.5 - 30.425.66In
 Put
AXSM250417P001600001160.031.4 - 35.030.58In
 Put
AXSM250417P001650000165.036.1 - 39.736.1In
 Put
AXSM250417P001700000170.040.6 - 44.640.6In
 Put
AXSM250417P001750000175.045.7 - 49.545.7In
 Put
AXSM250417P001800000180.050.5 - 55.050.5In
 Put
AXSM250417P001850000185.055.2 - 60.055.2In
 Put
AXSM250417P001900000190.060.5 - 64.560.5In
 Put
AXSM250417P001950000195.065.5 - 69.565.5In
 Put
AXSM250417P002000000200.070.5 - 74.570.5In

Axsome Therapeutics Corporate Management

Hunter EsqGeneral SecretaryProfile
Amanda PharmDSenior DevelopmentProfile
Lori MBAExecutive DevelopmentProfile
Kevin PharmDEx StrategyProfile
Mark MAChief OfficerProfile
When determining whether Axsome Therapeutics is a strong investment it is important to analyze Axsome Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Axsome Therapeutics' future performance. For an informed investment choice regarding Axsome Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axsome Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.00)
Revenue Per Share
8.05
Quarterly Revenue Growth
0.66
Return On Assets
(0.27)
Return On Equity
(2.32)
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

TERN
Terns Pharmaceuticals
3.69  -0.07  -1.86 
ACAD
ACADIA Pharmaceuticals
19.60  0.26  1.34 
RETA
Reata Pharmaceuticals
0.00  0.00  0.00 
ICPT
Intercept Pharmaceuticals
0.00  0.00  0.00 
TGTX
TG Therapeutics
30.09  1.56  5.47 
AKRO
Akero Therapeutics
47.75  0.16  0.34 
VKTX
Viking Therapeutics
28.87  0.20  0.70 
PDSB
PDS Biotechnology Corp
1.33  -0.03  -2.21 
SRPT
Sarepta Therapeutics
106.75  3.69  3.58 
MCRB
Seres Therapeutics
0.76  0.03  4.11 
HEPA
Hepion Pharmaceuticals
0.13  -0.01  -7.14 
IMGN
ImmunoGen
0.00  0.00  0.00 
MDGL
Madrigal Pharmaceuticals
341.27  5.53  1.65 
DAWN
Day One Biopharmaceu
9.06  -0.38  -4.03 
BPMC
Blueprint Medicines Corp
96.57  6.15  6.80 
INCY
Incyte
73.50  0.32  0.44 
AMLX
Amylyx Pharmaceuticals
3.28  0.12  3.80 
News Freq…Investor S…100%